HomePharma

Pharma

Pharma

Delix Therapeutics Study Shows Non-Hallucinogenic Compound Zalsupindole Promotes Neuroplasticity Comparable to Ketamine and Psychedelics

Life Sciences Times - 0
Pharma

Cycle Pharmaceuticals Launches PHYRAGO in U.S., Its First Oncology Treatment

Life Sciences Times - 0
Pharma

ClearB Therapeutics Advances Phase 1b Trial of CLB-4000 for Chronic Hepatitis B Following Positive Safety Review

Life Sciences Times - 0
Pharma

PeptiDream, PDRadiopharma and Curium Begin Phase 2 Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

Life Sciences Times - 0
Pharma

Alzheon Publishes Peer-Reviewed Results from Pivotal Phase 3 APOLLOE4 Trial of Oral Valiltramiprosate in APOE4/4 Homozygous Patients with Early Alzheimer’s Disease

Life Sciences Times - 0
Pharma

Akamis Bio Receives FDA Fast Track Designation for NG-350A in Treatment of Locally Advanced Rectal Cancer

Life Sciences Times - 0
Pharma

Prilenia and Ferrer Present New Data Highlighting Pridopidine’s Sustained Benefits in Huntington’s Disease at 2025 HSG Congress

Life Sciences Times - 0
Pharma

Stoke Therapeutics and Biogen Report Long-Term Data Supporting Zorevunersen’s Potential as a Disease-Modifying Therapy for Dravet Syndrome

Life Sciences Times - 0
Pharma

Kernal Bio Secures Up to $48 Million from ARPA-H to Advance In Vivo CAR T-Cell Therapies for Cancer and Autoimmune Disease

Life Sciences Times - 0
Pharma

Astria Therapeutics Launches Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart for Hereditary Angioedema

Life Sciences Times - 0
Pharma

FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Life Sciences Times - 0
Pharma

Sarepta to Showcase New Neuromuscular Data at World Muscle Society Congress

Life Sciences Times - 0
1...91011...91Page 10 of 91

Most Read